Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gastric acid reduction leads to an alteration in lower intestinal microflora.
Kanno T, Matsuki T, Oka M, Utsunomiya H, Inada K, Magari H, Inoue I, Maekita T, Ueda K, Enomoto S, Iguchi M, Yanaoka K, Tamai H, Akimoto S, Nomoto K, Tanaka R, Ichinose M. Kanno T, et al. Among authors: yanaoka k. Biochem Biophys Res Commun. 2009 Apr 17;381(4):666-70. doi: 10.1016/j.bbrc.2009.02.109. Epub 2009 Feb 25. Biochem Biophys Res Commun. 2009. PMID: 19248769
Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils.
Magari H, Shimizu Y, Inada K, Enomoto S, Tomeki T, Yanaoka K, Tamai H, Arii K, Nakata H, Oka M, Utsunomiya H, Tsutsumi Y, Tsukamoto T, Tatematsu M, Ichinose M. Magari H, et al. Among authors: yanaoka k. Biochem Biophys Res Commun. 2005 Aug 26;334(2):606-12. doi: 10.1016/j.bbrc.2005.06.132. Biochem Biophys Res Commun. 2005. PMID: 16009342
Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M, Magari H, Utsunomiya H, Tamai H, Arii K, Ohata H, Fujishiro M, Takeshita T, Mohara O, Ichinose M. Yanaoka K, et al. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):838-45. doi: 10.1158/1055-9965.EPI-07-2762. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18398025 Clinical Trial.
Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Inoue I, Iguchi M, Maekita T, Ueda K, Utsunomiya H, Tamai H, Fujishiro M, Iwane M, Takeshita T, Mohara O, Ichinose M. Yanaoka K, et al. Int J Cancer. 2009 Dec 1;125(11):2697-703. doi: 10.1002/ijc.24591. Int J Cancer. 2009. PMID: 19610064 Free article.
Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion.
Yanaoka K, Oka M, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Maekita T, Inoue I, Ueda K, Utsunomiya H, Iguchi M, Tamai H, Fujishiro M, Nakamura Y, Tsukamoto T, Inada K, Takeshita T, Ichinose M. Yanaoka K, et al. Int J Cancer. 2010 Mar 15;126(6):1467-73. doi: 10.1002/ijc.24862. Int J Cancer. 2010. PMID: 19711347 Free article. Clinical Trial.
Inhibitory effects of Japanese apricot (Prunus mume Siebold et Zucc.; Ume) on Helicobacter pylori-related chronic gastritis.
Enomoto S, Yanaoka K, Utsunomiya H, Niwa T, Inada K, Deguchi H, Ueda K, Mukoubayashi C, Inoue I, Maekita T, Nakazawa K, Iguchi M, Arii K, Tamai H, Yoshimura N, Fujishiro M, Oka M, Ichinose M. Enomoto S, et al. Among authors: yanaoka k. Eur J Clin Nutr. 2010 Jul;64(7):714-9. doi: 10.1038/ejcn.2010.70. Epub 2010 Jun 2. Eur J Clin Nutr. 2010. PMID: 20517325
Serum pepsinogen and gastric cancer screening.
Mukoubayashi C, Yanaoka K, Ohata H, Arii K, Tamai H, Oka M, Ichinose M. Mukoubayashi C, et al. Among authors: yanaoka k. Intern Med. 2007;46(6):261-6. doi: 10.2169/internalmedicine.46.6181. Epub 2007 Mar 15. Intern Med. 2007. PMID: 17379991 Free article. Review.
Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level.
Enomoto S, Tamai H, Oka M, Shingaki N, Shiraki T, Takeuchi M, Deguchi H, Magari H, Inoue I, Iguchi M, Yanaoka K, Arii K, Fujishiro M, Yahagi N, Yotsuyanagi H, Ichinose M. Enomoto S, et al. Among authors: yanaoka k. Hepatol Res. 2007 Sep;37(9):692-700. doi: 10.1111/j.1872-034X.2007.00112.x. Epub 2007 Jun 15. Hepatol Res. 2007. PMID: 17573949
52 results